• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝前列素通过调节 Nedd4 诱导的 Runx2 泛素化来改善绝经后骨质疏松症。

Beraprost ameliorates postmenopausal osteoporosis by regulating Nedd4-induced Runx2 ubiquitination.

机构信息

Department of Clinic of Spine Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, 200082, Shanghai, China.

出版信息

Cell Death Dis. 2021 May 15;12(5):497. doi: 10.1038/s41419-021-03784-8.

DOI:10.1038/s41419-021-03784-8
PMID:33993186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8124066/
Abstract

Bone health requires adequate bone mass, which is maintained by a critical balance between bone resorption and formation. In our study, we identified beraprost as a pivotal regulator of bone formation and resorption. The administration of beraprost promoted differentiation of mouse bone mesenchymal stem cells (M-BMSCs) through the PI3K-AKT pathway. In co-culture, osteoblasts stimulated with beraprost inhibited osteoclastogenesis in a rankl-dependent manner. Bone mass of p53 knockout mice remained stable, regardless of the administration of beraprost, indicating that p53 plays a vital role in the bone mass regulation by beraprost. Mechanistic in vitro studies showed that p53 binds to the promoter region of neuronal precursor cell-expressed developmentally downregulated 4 (Nedd4) to promote its transcription. As a ubiquitinating enzyme, Nedd4 binds to runt-related transcription factor 2 (Runx2), which results in its ubiquitination and subsequent degradation. These data indicate that the p53-Nedd4-Runx2 axis is an effective regulator of bone formation and highlight the potential of beraprost as a therapeutic drug for postmenopausal osteoporosis.

摘要

骨骼健康需要足够的骨量,而这是通过骨吸收和形成之间的关键平衡来维持的。在我们的研究中,我们发现贝前列素是骨形成和吸收的关键调节因子。贝前列素的给药通过 PI3K-AKT 途径促进了小鼠骨髓间充质干细胞(M-BMSCs)的分化。在共培养中,贝前列素刺激的成骨细胞以依赖 rankl 的方式抑制破骨细胞生成。无论是否给予贝前列素,p53 敲除小鼠的骨量保持稳定,这表明 p53 在贝前列素调节骨量方面起着至关重要的作用。体外机制研究表明,p53 与神经元前体细胞表达的发育下调 4(Nedd4)的启动子区域结合,促进其转录。作为一种泛素化酶,Nedd4 与 runt 相关转录因子 2(Runx2)结合,导致其泛素化和随后的降解。这些数据表明,p53-Nedd4-Runx2 轴是骨形成的有效调节因子,并突出了贝前列素作为绝经后骨质疏松症治疗药物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/92044b4436d5/41419_2021_3784_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/bf53db798280/41419_2021_3784_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/26cf3d5d9eb1/41419_2021_3784_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/d93e7d34aec7/41419_2021_3784_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/a10e70fe279d/41419_2021_3784_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/e2523e7db7b8/41419_2021_3784_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/640e6ca6b457/41419_2021_3784_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/92044b4436d5/41419_2021_3784_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/bf53db798280/41419_2021_3784_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/26cf3d5d9eb1/41419_2021_3784_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/d93e7d34aec7/41419_2021_3784_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/a10e70fe279d/41419_2021_3784_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/e2523e7db7b8/41419_2021_3784_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/640e6ca6b457/41419_2021_3784_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e2/8124066/92044b4436d5/41419_2021_3784_Fig7_HTML.jpg

相似文献

1
Beraprost ameliorates postmenopausal osteoporosis by regulating Nedd4-induced Runx2 ubiquitination.贝前列素通过调节 Nedd4 诱导的 Runx2 泛素化来改善绝经后骨质疏松症。
Cell Death Dis. 2021 May 15;12(5):497. doi: 10.1038/s41419-021-03784-8.
2
The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation.E3泛素连接酶WWP2在成骨分化过程中以单泛素化方式促进RUNX2蛋白的反式激活。
J Biol Chem. 2017 Jul 7;292(27):11178-11188. doi: 10.1074/jbc.M116.772277. Epub 2017 May 12.
3
Pilose antler aqueous extract promotes the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells by stimulating the BMP-2/Smad1, 5/Runx2 signaling pathway.鹿茸水提物通过刺激 BMP-2/Smad1、5/Runx2 信号通路促进骨髓间充质干细胞的增殖和成骨分化。
Chin J Nat Med. 2019 Oct;17(10):756-767. doi: 10.1016/S1875-5364(19)30092-5.
4
Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.贝拉前列腺素:其药理学及治疗外周动脉疾病和肺动脉高压疗效的综述
Drugs. 2002;62(1):107-33. doi: 10.2165/00003495-200262010-00005.
5
Sweroside-mediated mTORC1 hyperactivation in bone marrow mesenchymal stem cells promotes osteogenic differentiation.唾液酸苷酶介导的骨髓间充质干细胞中 mTORC1 的过度激活促进成骨分化。
J Cell Biochem. 2019 Sep;120(9):16025-16036. doi: 10.1002/jcb.28882. Epub 2019 May 9.
6
Beneficial effects of beraprost sodium, a stable prostacyclin analogue, in diabetic cardiomyopathy.稳定的前列环素类似物贝拉普罗斯钠对糖尿病性心肌病的有益作用。
J Cardiovasc Pharmacol. 1995 Oct;26(4):603-7. doi: 10.1097/00005344-199510000-00015.
7
Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.大环内酯 F 通过抑制 Akt、MAPK 和 NFATc1 通路抑制 RANKL 介导的破骨细胞生成,并通过 BMP-2/smad/Akt/Runx2 信号通路促进成骨细胞生成。
Eur J Pharmacol. 2017 Nov 15;815:202-209. doi: 10.1016/j.ejphar.2017.09.015. Epub 2017 Sep 15.
8
Effect of beraprost sodium (Procylin), a stable prostaglandin I2 analogue, on a dorsal skin flap model in rats.稳定的前列环素I2类似物贝拉前列素钠(前列环素)对大鼠背部皮瓣模型的影响。
Scand J Plast Reconstr Surg Hand Surg. 1996 Mar;30(1):17-22. doi: 10.3109/02844319609072399.
9
[Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue].[贝前列素钠的药理及临床特性,口服活性前列环素类似物]
Nihon Yakurigaku Zasshi. 2001 Feb;117(2):123-30. doi: 10.1254/fpj.117.123.
10
Inhibitory effects of beraprost on platelet aggregation: comparative study utilizing two methods of aggregometry.贝拉前列素对血小板聚集的抑制作用:采用两种血小板聚集测定方法的比较研究。
Thromb Res. 1999 Apr 1;94(1):25-32. doi: 10.1016/s0049-3848(98)00187-x.

引用本文的文献

1
Posttranslational Modification in Bone Homeostasis and Osteoporosis.骨稳态与骨质疏松中的翻译后修饰
MedComm (2020). 2025 Apr 1;6(4):e70159. doi: 10.1002/mco2.70159. eCollection 2025 Apr.
2
PML Regulated HIF1AN Ubiquitination and Activated PI3K/AKT Pathway to Promote Bone Marrow Mesenchymal Stem Cells Osteogenic Differentiation.PML调控HIF1AN泛素化并激活PI3K/AKT通路以促进骨髓间充质干细胞成骨分化。
Int J Stem Cells. 2025 May 30;18(2):146-157. doi: 10.15283/ijsc24110. Epub 2025 Mar 10.
3
MiR-147b-3p promotes osteogenesis by targeting NDUFA4 and PI3K/AKT pathway.

本文引用的文献

1
A novel negative regulatory mechanism of Smurf2 in BMP/Smad signaling in bone.Smurf2在骨骼中BMP/Smad信号通路中的一种新型负调控机制。
Bone Res. 2020 Nov 23;8(1):41. doi: 10.1038/s41413-020-00115-z.
2
New anti-osteoporosis drug target identified.发现新的抗骨质疏松药物靶点。
Nat Rev Endocrinol. 2021 Jan;17(1):4-5. doi: 10.1038/s41574-020-00441-6.
3
Cadmium exposure triggers osteoporosis in duck via P2X7/PI3K/AKT-mediated osteoblast and osteoclast differentiation.镉暴露通过 P2X7/PI3K/AKT 介导的成骨细胞和破骨细胞分化引发鸭骨质疏松症。
微小RNA-147b-3p通过靶向NDUFA4和PI3K/AKT信号通路促进成骨作用。
J Orthop Surg Res. 2025 Mar 4;20(1):235. doi: 10.1186/s13018-025-05598-2.
4
Hypoxia Promotes Osteoclast Differentiation by Weakening USP18-Mediated Suppression on the NF-κB Signaling Pathway.缺氧通过减弱USP18介导的对NF-κB信号通路的抑制作用来促进破骨细胞分化。
Int J Mol Sci. 2024 Dec 24;26(1):10. doi: 10.3390/ijms26010010.
5
Enhancing postmenopausal osteoporosis: a study of KLF2 transcription factor secretion and PI3K-Akt signaling pathway activation by PIK3CA in bone marrow mesenchymal stem cells.增强绝经后骨质疏松症:一项关于骨髓间充质干细胞中KLF2转录因子分泌及PIK3CA对PI3K-Akt信号通路激活作用的研究。
Arch Med Sci. 2024 May 15;20(3):918-937. doi: 10.5114/aoms/171785. eCollection 2024.
6
Osteoporotic osseointegration: therapeutic hallmarks and engineering strategies.骨质疏松性骨整合:治疗特征和工程策略。
Theranostics. 2024 Jun 17;14(10):3859-3899. doi: 10.7150/thno.96516. eCollection 2024.
7
Role of ubiquitination in the occurrence and development of osteoporosis (Review).泛素化在骨质疏松症发生发展中的作用(综述)。
Int J Mol Med. 2024 Aug;54(2). doi: 10.3892/ijmm.2024.5392. Epub 2024 Jun 28.
8
Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway.六味地黄丸通过激活Wnt/β-连环蛋白信号通路增强MC3T3-E1细胞的成骨分化。
Pharmaceuticals (Basel). 2024 Jan 11;17(1):99. doi: 10.3390/ph17010099.
9
The Secondary Metabolites of Bacillus subtilis Strain Z15 Induce Apoptosis in Hepatocellular Carcinoma Cells.枯草芽孢杆菌Z15菌株的次生代谢产物诱导肝癌细胞凋亡
Probiotics Antimicrob Proteins. 2025 Apr;17(2):832-842. doi: 10.1007/s12602-023-10181-4. Epub 2023 Oct 31.
10
The role of E3 ubiquitin ligases in bone homeostasis and related diseases.E3泛素连接酶在骨稳态及相关疾病中的作用。
Acta Pharm Sin B. 2023 Oct;13(10):3963-3987. doi: 10.1016/j.apsb.2023.06.016. Epub 2023 Jul 6.
Sci Total Environ. 2021 Jan 1;750:141638. doi: 10.1016/j.scitotenv.2020.141638. Epub 2020 Aug 15.
4
p53 plays a central role in the development of osteoporosis.p53 在骨质疏松症的发展中起着核心作用。
Aging (Albany NY). 2020 Jun 2;12(11):10473-10487. doi: 10.18632/aging.103271.
5
Resveratrol promotes osteogenesis and alleviates osteoporosis by inhibiting p53.白藜芦醇通过抑制 p53 促进成骨作用并缓解骨质疏松症。
Aging (Albany NY). 2020 May 27;12(11):10359-10369. doi: 10.18632/aging.103262.
6
Bone marrow mesenchymal stem cells improve bone erosion in collagen-induced arthritis by inhibiting osteoclasia-related factors and differentiating into chondrocytes.骨髓间充质干细胞通过抑制破骨细胞相关因子和分化为软骨细胞来改善胶原诱导性关节炎的骨侵蚀。
Stem Cell Res Ther. 2020 May 7;11(1):171. doi: 10.1186/s13287-020-01684-w.
7
Synthesis and biological activities of drugs for the treatment of osteoporosis.骨质疏松症治疗药物的合成与生物活性。
Eur J Med Chem. 2020 Jul 1;197:112313. doi: 10.1016/j.ejmech.2020.112313. Epub 2020 Apr 19.
8
TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma.TAK1 是骨髓瘤中肿瘤进展和骨破坏的关键治疗靶点。
Haematologica. 2021 May 1;106(5):1401-1413. doi: 10.3324/haematol.2019.234476.
9
A broader strategy for osteoporosis interventions.骨质疏松症干预的更广泛策略。
Nat Rev Endocrinol. 2020 Jun;16(6):333-339. doi: 10.1038/s41574-020-0339-7. Epub 2020 Mar 17.
10
Bisphosphonates for Osteopenia in Postmenopausal Women.双膦酸盐用于绝经后女性骨质减少症
JAMA. 2020 Mar 17;323(11):1096. doi: 10.1001/jama.2020.0602.